Approval · Notice of Compliance 20117 · 2017
NORVIR: Notice of Compliance 20117
Issued November 27, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20117
- Date
- November 27, 2017
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the inner and outer labels, and the package insert for the 100 mg tablets, and pharmacovigilance information in the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORVIR | Not yet assigned | — |